Intercure (INCR) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Intercure in June 2026.
Stock Performance Snapshot
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring INCR
Cannabis Reclassification | Schedule III Tax Relief
The DOJ's historic move to reclassify marijuana as a Schedule III drug is removing massive tax burdens and sparking immediate optimism across the cannabis sector. This policy shift unlocks new profitability and operational pathways for medical producers, dispensaries, and pharmaceutical researchers navigating the newly regulated landscape.
Published: April 24, 2026
Explore BasketWhy You’ll Want to Watch This Stock
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.